Immune-Therapy-Related Toxicity Events and Dramatic Remission After a Single Dose of Pembrolizumab Treatment in Metastatic Thymoma: A Case Report

Immune-Therapy-Related Toxicity Events and Dramatic Remission After a Single Dose of Pembrolizumab Treatment in Metastatic Thymoma: A Case Report

Immune checkpoint inhibitor therapy has become a promising option for the treatment of late-stage thymic epithelial tumors. In this manuscript, we presented a patient with metastatic thymoma administrated of anti-programmed cell death protein 1 (PD-1) antibody pembrolizumab. Although the patient und...

Full description

Bibliographic Details
Main Authors:	Li Shen, Haiyan Chen, Qichun Wei
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-04-01
Series:	Frontiers in Immunology
Subjects:	thymoma pembrolizumab immune-therapy–related toxicity events case report immunotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.621858/full

Similar Items

Durable complete remission after Pembrolizumab in pretreated advanced endometrial cancer: A case report
by: Bacigalupo, L., et al.
Published: (2022)

Refractory Bullous Pemphigoid in a Patient with Metastatic Lung Adenocarcinoma Treated with Pembrolizumab
by: Andrés F. Cardona, et al.
Published: (2021-03-01)

Case Report: Lymphocytosis Associated With Fatal Hepatitis in a Thymoma Patient Treated With Anti-PD1: New Insight Into the Immune-Related Storm
by: Antonella Argentiero, et al.
Published: (2020-12-01)

Immune Checkpoint Inhibitors for the Therapy of Thymoma
by: Alicia Quilez, MD, et al.
Published: (2020-03-01)

Treatment Considerations for Patients with Unresectable Metastatic Melanoma Who Develop Pembrolizumab-Induced Guillain-Barré Toxicity: A Case Report
by: Sivraj Muralikrishnan, et al.
Published: (2020-01-01)

Case report: reinitiating pembrolizumab treatment after small bowel perforation
by: Tim N. Beck, et al.
Published: (2019-04-01)

Immune biomarkers of treatment failure for a patient on a phase I clinical trial of pembrolizumab plus radiotherapy
by: Gregory S. Alexander, et al.
Published: (2016-09-01)

Single Center Experience Study with Pembrolizumab in Patients with BRAF Mutant Negative Metastatic Melanoma
by: Pejčić Ivica, et al.
Published: (2018-12-01)

Complete remission of advanced lung adenocarcinoma with first-line pembrolizumab monotherapy: Two case reports
by: Kazuki Gohara, et al.
Published: (2021-01-01)

Pembrolizumab-Induced Psoriasis in Metastatic Melanoma: Activity and Safety of Apremilast, a Case Report
by: Maria Anna Siciliano, et al.
Published: (2020-10-01)

AIHA and Pancytopenia as Complications of Pembrolizumab Therapy for Metastatic Melanoma: A Case Report
by: Dan Ni, et al.
Published: (2019-06-01)

Bullous pemphigoid secondary to pembrolizumab mimicking toxic epidermal necrolysis
by: Connie Qiu, BS, et al.
Published: (2020-05-01)

Pembrolizumab‐axitinib‐induced tumor lysis syndrome in a patient with metastatic renal cancer
by: Manan Shah, et al.
Published: (2020-04-01)

Potential of Pembrolizumab in Metastatic or Recurrent Head and Neck Cancer: Evidence to Date
by: McCusker MG, et al.
Published: (2020-04-01)

Complete Pathologic Responses With Immunotherapy in Metastatic Renal Cell Carcinoma: Case Reports
by: Matthew D. Tucker, et al.
Published: (2020-12-01)

Dermatologic Toxicities of Targeted Therapy and Immunotherapy in Head and Neck Cancers
by: Maria L. Espinosa, et al.
Published: (2021-05-01)

Bilateral single-port thoracoscopic extended thymectomy for management of thymoma and myasthenia gravis: case report
by: Francesco Paolo Caronia, et al.
Published: (2016-11-01)

Retrospective analysis of treatment-naive Slovenian patients with metastatic melanoma treated with pembrolizumab – real-world experience
by: Hribernik Nezka, et al.
Published: (2020-01-01)

A case of thymoma with type A and micronodular thymoma with lymphoid stroma elements
by: Clayton E. Kibler, et al.
Published: (2021-03-01)

Development of drug-induced arthritis in a glioblastoma patient treated with pembrolizumab
by: Casey B Brown, et al.
Published: (2018-01-01)

Rapid progression of thymoma in a 3-year-old-girl
by: Hui-Ling Peng, et al.
Published: (2019-01-01)

Primary Intrapulmonary Thymoma Appearing as a Solitary Pulmonary Nodule: The “Master of Disguise” of Lung Tumors?: Case Report
by: Athanasios Krassas, et al.
Published: (2021-10-01)

Public Adverse Event Data Insights into the Safety of Pembrolizumab in Melanoma Patients
by: Anne Schaefer, et al.
Published: (2020-04-01)

The role of Thymectomy in Remission of Myasthenia gravis patients with or without Thymoma
by: Manouchehr Aghajanzadeh, et al.
Published: (2011-09-01)

Pulmonary Sarcoidosis Activation following Neoadjuvant Pembrolizumab plus Chemotherapy Combination Therapy in a Patient with Non-Small Cell Lung Cancer: A Case Report
by: Ghina Fakhri, et al.
Published: (2017-11-01)

Debilitating Skin Toxicity Associated with Pembrolizumab Therapy in an 81-Year-Old Female with Malignant Melanoma
by: Muhammad O. Khokhar, et al.
Published: (2016-12-01)

Severe immune mucositis and esophagitis in metastatic squamous carcinoma of the larynx associated with pembrolizumab
by: Fanny Zulay Acero Brand, et al.
Published: (2018-03-01)

Pembrolizumab as Consolidation Strategy in Patients with Multiple Myeloma: Results of the GEM-Pembresid Clinical Trial
by: Noemí Puig, et al.
Published: (2020-12-01)

Remission of Thymoma on Steroid Therapy in a Patient With Atypical Thymoma-Associated Multiorgan Autoimmunity: A Case Report and Literature Review
by: Ewa Wrona, et al.
Published: (2021-04-01)

Response of Metastatic Chordoma to the Immune Checkpoint Inhibitor Pembrolizumab: A Case Report
by: Xiaoli Wu, et al.
Published: (2020-12-01)

Case Report: Two Cases of Chemotherapy Refractory Metastatic Penile Squamous Cell Carcinoma With Extreme Durable Response to Pembrolizumab
by: Jad Chahoud, et al.
Published: (2020-12-01)

Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinoma
by: Evidio Domingo-Musibay, et al.
Published: (2018-06-01)

Symptomatic methemoglobinemia in a patient with metastatic clear cell renal cell carcinoma treated with pembrolizumab and axitinib combination therapy: a case report
by: T. Anders Olsen, et al.
Published: (2021-02-01)

Cervical thymoma
by: Abrão Rapoport, et al.
Published: (1999-05-01)

Multifocal Primary Intrapulmonary Thymoma: A rare subtype of ectopic thymoma
by: Albert Iruthiaraj Lourdesamy Anthony, et al.
Published: (2021-01-01)

Complete Pathologic Response After Concurrent Treatment with Pembrolizumab and Radiotherapy in Metastatic Colorectal Cancer: A Case Report
by: Yang J, et al.
Published: (2021-04-01)

Complete response to the combination of Lenvatinib and Pembrolizumab in an advanced hepatocellular carcinoma patient: a case report
by: Zhaonan Liu, et al.
Published: (2019-11-01)

Pembrolizumab Induced Ocular Hypotony With Near Complete Vision Loss, Interstitial Pulmonary Fibrosis and Arthritis
by: Mike Nguyen, et al.
Published: (2019-09-01)

Surgical treatment of micronodular thymoma with lymphoid stroma
by: Min Kyun Kang, et al.
Published: (2020-04-01)

Pembrolizumab‐related pancreatitis with elevation of pancreatic tumour markers
by: Tamaki Kakuwa, et al.
Published: (2020-03-01)